Lovastatin (Compound)

Synonyms:lovastatin, 75330-75-5, mevinolin, Mevacor, Altoprev, Mevlor, Sivlor, MK-803, Monacolin K, Lovalord, Nergadan, Artein, 6alpha-Methylcompactin, Lovalip, Lovastatine [French], Lovastatinum [Latin], Lovastatina [Spanish], 6-alpha-Methylcompactin, Mevinacor, Altocor, Hipovastin, Lovasterol, Cholestra, Closterol, Colevix, Hipolip, Lestatin, Lipivas, Lipofren, Lovastin, Lozutin, Paschol, Rodatin, Rovacor, Tecnolip, Teroltrat, Belvas, Lipdip, Taucor, Lovastatin [USAN], MLS000069585, 6.alpha.-Methylcompactin, MSD 803, Lovastatin (MK-803), 9LHU78OQFD, [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate, NSC-758662, L-154803, MK 803, 2beta,6alpha-Dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinic acid lactone, SMR000058779, (1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate, butanoic acid, 2-methyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester, (2S)-, Lovastatine, DTXSID5020784, CHEBI:40303, C10AA02, Lovastatin (Mevacor), (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-(2-(2R,4R)-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl (S)-2-methyl-butyrate, (1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate, HSDB 6534, NCGC00023509-03, Lovastatina, Lovastatinum, DTXCID50784, Liposcler, 6 alpha-Methylcompactin, Rextat, Monakolin K, (1S,3R,7S,8S,8aR)-8-(2-((2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (S)-2-methylbutanoate, (S)-(1S,3R,7S,8S,8aR)-8-(2-((2R,4R)-4-Hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2-methylbutanoate, Mevacor (TN), CHEMBL503, Lovastatin & Primycin, Lovastatin (USP/INN), SR-05000001880, (1S-(1alpha(R*),3alpha,7beta,8beta(2S*,4S*),8abeta))-2-Methylbutanoic acid 1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (S)-2-Methylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8aR)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one, 1,2,6,7,8,8a-Hexahydro-beta,delta-dihydroxy-2,6-dimethyl-8-(2-methyl-1-oxobutyoxy)-1-naphthaleneheptanoic acid delta-lactone, UNII-9LHU78OQFD, BRN 3631989, Mevinolin from Aspergillus sp., CCRIS 8092, 1cqp, Lovastatin,(S), ML-530B, Lovastatin [USAN:USP:INN:BAN], (+)-mevinolin, (2S)-2-METHYLBUTANOIC ACID (1S,3R,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-3,7-DIMETHYL-8-(2-((2R,4R)-TETRAHYDRO-4-HYDROXY-6-OXO-2H-PYRAN-2-YL)ETHYL)-1-NAPHTHALENYL ESTER, (2S)-2-Methylbutanoic acid (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester, (S)-((1S,3R,7S,8S,8aR)-8-(2-((2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl) 2-methylbutanoate, [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxo-tetrahydropyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate, Butanoic acid, 2-methyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (2S)-, Lovastatin- Bio-X, Prestwick_819, CAS-75330-75-5, MFCD00072164, Mevinolin (lovastatin), Lovastatin (Mevinolin), LOVASTATIN [MI], LOVASTATIN [INN], Opera_ID_1578, Prestwick0_000516, Prestwick1_000516, Prestwick2_000516, Prestwick3_000516, Spectrum3_001873, Spectrum5_001294, LOVASTATIN [HSDB], LOVASTATIN [VANDF], EC 616-212-7, LOVASTATIN [MART.], SCHEMBL3136, LOVASTATIN [USP-RS], LOVASTATIN [WHO-DD], US9115116, lovastatin, BIDD:PXR0113, BSPBio_000471, BSPBio_001265, BSPBio_003346, Butanoic acid, 2-methyl-, 1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (1S-(1alpha(R*),3alpha,7beta,8beta(2S*,4S*),8abeta))-, cid_53232, MLS001055358, MLS006011867, US9353061, Lovastatina, BIDD:GT0749, DivK1c_001032, SPECTRUM1503977, SPBio_002392, BPBio1_000519, GTPL2739, MEGxm0_000398, LOVASTATIN [ORANGE BOOK], SCHEMBL14227102, ACon0_000534, ACon1_000390, BDBM34168, HMS503O05, KBio1_001032, KBio3_002848, LOVASTATIN [EP MONOGRAPH], Simvastatin impurity, lovastatin-, Lovastatin for peak identification, NINDS_001032, HMS1569H13, HMS1792O07, HMS1923O13, HMS1990O07, HMS2089M06, HMS2093O03, HMS2096H13, HMS2236F07, HMS3039N16, HMS3259F10, HMS3268C03, HMS3403O07, HMS3412H19, HMS3676H19, HMS3713H13, HMS3884B03, LOVASTATIN [USP MONOGRAPH], Pharmakon1600-01503977, ADVICOR COMPONENT LOVASTATIN, (S)-2-Methylbutyric acid, 8-ester with (4R,6R)-6-[2-[(1S,2S,6R,8S,8aR)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl]ethyl]tetrahydro-4-hydroxy-2H-pyran-2-one, ACT02620, ALBB-027272, HY-N0504, MK-803; LOVALIP; MEVACOR, Tox21_110888, Tox21_201475, Tox21_300268, BBL024473, CCG-39627, NSC633781, NSC758662, NSC779704, s2061, STK801953, AKOS005267139, LOVASTATIN COMPONENT OF ADVICOR, Tox21_110888_1, CS-1990, DB00227, KS-1082, Mevinolin from Aspergillus sp., powder, NC00713, NSC 758662, NSC-633781, NSC-779704, IDI1_001032, NCGC00023509-04, NCGC00023509-05, NCGC00023509-06, NCGC00023509-07, NCGC00023509-08, NCGC00023509-09, NCGC00023509-10, NCGC00023509-11, NCGC00023509-13, NCGC00023509-14, NCGC00023509-16, NCGC00254157-01, NCGC00259026-01, 74133-25-8, AC-13961, BL164644, Butanoic acid, 2-methyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (2S)-, G226, SMR000673570, SBI-0051881.P002, L0214, SIMVASTATIN IMPURITY E [EP IMPURITY], EN300-52515, C07074, D00359, AB00052400-17, AB00052400_18, AB00052400_19, Mevinolin from Aspergillus sp., >=98% (HPLC), A838030, A838383, Q417740, SR-01000000123, SR-01000000123-3, SR-05000001880-1, SR-05000001880-2, BRD-K09416995-001-06-8, BRD-K09416995-001-21-7, Mevacor;Monacolin K;mevinolin;6-alpha-Methylcompactin, SIMVASTATIN IMPURITY, LOVASTATIN- [USP IMPURITY], Z754931258, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-8-(2-((4R,6R)-4-hydroxy-2-oxo-2H-pyran-6-yl)ethyl)-3,7-dimethylnaphtyl(S)-2-methylbutyrat, (2S)-(1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl-2-methyl butanoate, (2S)-2-methylbutanoic acid [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxo-2-oxanyl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] ester, (S)-((1S,3R,7S,8S,8AR)-8-(2-((2R,4R)-4-HYDROXY-6-OXO-TETRAHYDRO-2H-PYRAN-2-YL)ETHYL)-3,7-DIMETHYL-1,2,3,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL) 2-METHYLBUTANOATE, (S)-2-Methyl-butyric acid (1S,3R,7S,8S,8aR)-8-[2-((3R,5R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl ester, [(1S,3R,7S,8S,8aR)-3,7-dimethyl-8-[2-[(2R,4R)-4-oxidanyl-6-oxidanylidene-oxan-2-yl]ethyl]-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate, [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-Hydroxy-6-oxo-tetrahydropyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2-methylbutanoate, 1S,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate, 8-[2-(4-Hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydro-1-naphthale, Butanoic acid, 2-methyl-, 1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-- oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (1S-(1alpha(R*),3alpha,7beta,8beta(2S*,4S*),8abeta))-, BUTANOIC ACID, 2-METHYL-, 1,2,3,7,8,8A-HEXAHYDRO-3,7-DIMETHYL-8-(2-(TETRAHYDRO-4-HYDROXY-6-OXO-2H-PYRAN-2-YL)ETHYL)-1-NAPHTHALENYL ESTER, (1S-(1.ALPHA.(R*),3.ALPHA.,7.BETA.,8.BETA.(2S*,4S*),8.ALPHA..BETA.))-

Id:53232

Description:nan